8-K: SKYX Platforms Secures $4M Private Placement

SKYX Platforms Corp. announced a $4 million private placement of common stock with a new strategic investor to bolster working capital.

Summary

• SKYX Platforms Corp. entered into a Securities Purchase Agreement with a new strategic investor on January 7, 2026.
• The company closed on gross proceeds of $4,000,000 from this transaction.
• The investor purchased 2,000,000 shares of the company's common stock at a purchase price of $2.00 per share.
• The proceeds from the sale are intended for general working capital and other corporate purposes.
• The issuance of these shares was deemed exempt from registration under Section 4(a)(2) of the Securities Act of 1933, including Regulation D and Rule 506.
• The company is obligated to file a Registration Statement for the resale of these common shares within 30 days of the closing date and use commercially reasonable efforts to have it declared effective within 90 days.
• A 'Conversion Share Cap' limits the aggregate number of shares deliverable to the investor to 19.99% of the common stock or voting power outstanding prior to the agreement date, unless stockholder approval is obtained.

Sentiment

Score: 6

Explanation: The capital raise provides necessary working capital and attracts a strategic investor, which are positive for the company's financial stability. However, the immediate dilution from new shares and the 19.99% cap requiring future shareholder approval introduce some caution, preventing a higher score.

Positives

• Secured $4,000,000 in gross proceeds, strengthening the company's financial position.
• The capital infusion is designated for general working capital and corporate purposes, supporting ongoing operations and strategic initiatives.
• Attracted a new strategic investor, potentially indicating confidence in the company's future and providing a long-term partner.
• The private placement structure allowed for efficient capital raising without the complexities and costs associated with a public offering.

Negatives

• The issuance of 2,000,000 new shares at $2.00 per share will result in dilution for existing shareholders.
• The 'Conversion Share Cap' of 19.99% of outstanding common stock or voting power requires future stockholder approval for any issuance beyond this threshold, which could introduce uncertainty or delays for larger capital needs or future transactions with this investor.

Risks

• Dilution Risk: The issuance of 2,000,000 new shares of common stock will dilute the ownership percentage of existing shareholders.
• Regulatory Compliance Risk: The company must comply with Nasdaq listing rules regarding the issuance of additional shares, including potentially obtaining stockholder approval if the issuance exceeds the 19.99% cap. Failure to do so could result in delisting.
• Registration Risk: While the company commits to filing a registration statement for resale, there is a risk that it may not become effective within the targeted 90-day period or that a stop order could be issued, affecting the investor's ability to sell shares.
• Market Price Impact: The potential sale of a significant block of shares by the strategic investor once registered could put downward pressure on the stock price.
• General Business Risks: The company's representations and warranties include standard business risks such as Material Adverse Effects, litigation, and compliance with various laws and regulations, which could impact its operations and financial condition.

Future Outlook

The company intends to use the $4,000,000 proceeds from the private placement for general working capital and other corporate purposes, which should support ongoing operations and strategic initiatives. It also plans to file a registration statement for the resale of the 2,000,000 common shares within 30 days of the closing date, aiming for effectiveness within 90 days, to provide liquidity for the strategic investor. Future share issuances related to this agreement may require stockholder approval if they exceed 19.99% of the outstanding common stock or voting power.

Management Comments

• The report was signed by Leonard J. Sokolow, Chief Executive Officer, on behalf of SKYX Platforms Corp.

Industry Context

na

Stakeholder Impact

• Shareholders: Existing shareholders will experience dilution due to the issuance of 2,000,000 new common shares. However, the capital raise could stabilize or improve the company's financial health, potentially benefiting long-term shareholder value.
• Company Operations: The $4,000,000 in proceeds will be used for general working capital and corporate purposes, supporting ongoing business operations and strategic initiatives.
• Strategic Investor: The new investor gains a significant stake (2,000,000 shares) and registration rights, providing a path to liquidity for their investment.

Next Steps

• Prepare and file a Registration Statement (Form S-3 or S-1) with the SEC covering the resale of the 2,000,000 common shares within 30 days following the Closing Date (by February 6, 2026).
• Use commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable, but no later than 90 days following the Closing Date (by April 6, 2026).
• Obtain requisite stockholder approval if the aggregate number of shares deliverable pursuant to the Transaction Documents to the Investor exceeds 19.99% of the common stock or voting power outstanding prior to closing.

Key Dates

Recommendation

The capital raise provides essential working capital and brings in a strategic investor, which are positive for the company's stability and future growth prospects. However, the immediate dilution from the issuance of 2 million shares at $2.00, coupled with the potential for further dilution if the 19.99% cap is exceeded and approved by shareholders, warrants a cautious 'hold' stance. Investors should monitor the company's use of proceeds, progress on the registration statement, and future operational performance to assess the long-term impact of this financing.

Keywords

SKYX Platforms, SKYX, Private Placement, Equity Raise, Common Stock, Strategic Investor, Working Capital, SEC Filing, Form 8-K, Securities Purchase Agreement, Capital Raise, Dilution, Nasdaq, Registration Rights